Mevion Medical Systems is set to install its MEVION S250 proton therapy system at the MedStar Georgetown University Hospital, located in Northwest Washington, Columbia, US.
The hospital has secured final approval to commence construction of the proton therapy center at its Lombardi Comprehensive Cancer Center.
The system will be used to treat adult and pediatric cancer patients. Proton therapy is used to treat different cancers in sensitive areas such as central nervous system, chest, head and neck, eye, and prostate.
MedStar plans to begin the construction of the center in this fall, while the installation of the system is expected to be completed in 2016.
MedStar Georgetown University Hospital president Richard Goldberg said the new technology will give patients yet another cutting-edge cancer treatment option.
"The addition of proton therapy to our experienced and internationally known cancer program is a natural progression for us as the only provider in the region with a long history of serving both children as well as adults with cancer," Goldberg added.
Mevion Medical Systems president and CEO Joseph Jachinow said: "The MEVION S250 proton therapy system provides a significant benefit to cancer patients while redefining the economics and accessibility of proton therapy."
Mevion also installed the system at the Kling Proton Therapy Center at Barnes-Jewish Hospital in Washington University of St. Louis, Missouri.
In addition, the systems are under installation at Robert Wood Johnson University Hospital in New Jersey, Stephenson Cancer Center at the University of Oklahoma, First Coast Oncology in Florida, University of Florida Health Cancer Center at Orlando Health and University Hospitals Seidman Cancer Center in Ohio.
Image: The MEVION S250 provides the benefits of proton therapy without the size, complexity and cost of traditional proton therapy treatments. Photo: courtesy of Business Wire.